Early-Stage cancer drug trial halted after enrolling just 3 patients
Disease control
Terminated
This study aimed to test if a new drug called CX-072, when combined with other cancer treatments, could shrink tumors in adults with advanced solid cancers like melanoma. It was a Phase 2 trial designed to measure how well the tumors responded to treatment and to check for side e…
Phase: PHASE2 • Sponsor: CytomX Therapeutics • Aim: Disease control
Last updated Mar 31, 2026 12:12 UTC